Sustained prophylactic effect of intravesical bacille Calmette- Guérin for superficial bladder cancer: A smoothed hazard analysis in a randomized prospective study

Urology

Volumn 67, Issue 3, 2006, Pages 545-549

  Hinotsu, Shiro ^b   Akaza, Hideyuki ^a   Isaka, Shigeo ^b   Kanetake, Hiroshi ^b   Kubota, Yoshinobu ^b   Kuroda, Masao ^b   Shinohara, Nobuo ^b   Shinka, Toshiaki ^b   Tachibana, Masaaki ^b   Naito, Seiji ^b   Hirao, Yoshihiko ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN;

ADULT; ARTHRALGIA; ARTICLE; BCG VACCINATION; BLADDER CANCER; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSURIA; ECG ABNORMALITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEMATURIA; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; POLLAKISURIA; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RISK ASSESSMENT; SIDE EFFECT; SKIN REDNESS; THORAX PAIN; TRANSURETHRAL RESECTION; TREATMENT DURATION; TUMOR CELL; TUMOR RECURRENCE; URINE CLOUDINESS; URINE COLOR; VACCINATION REACTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS;

EID: 33644745173     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.09.045     Document Type: Article

References (19)

1. N.M. Heney, S. Ahmed, M.J. Flanagan Superficial bladder cancer progression and recurrence J Urol 130 1983 1083 1086
2. S. Holmang, H. Hedelin, Anderstrom Recurrence and progression in low grade papillary urothelial tumors J Urol 162 1999 702 707
3. A. Morales, D. Eidinger, A.W. Bruce Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors J Urol 116 1976 180 183
4. H. Akaza, S. Hinotsu, Y. Aso Bacillus Calmette-Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder Cancer 75 1995 552 559
5. T. Niijima, K. Koiso, H. Akaza Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer Cancer Chemother Pharmacol 11 suppl 1983 S79 S82
6. H. Akaza, S. Isaka, K. Koiso Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer Cancer Chemother Pharmacol 20 suppl 1987 S91 S96
7. H. Akaza, K. Koiso, T. Kotake Long-term results of intravesical chemoprophylaxis of superficial bladder cancer experience of the Japanese Urological Cancer Research Group for Adriamycin Cancer Chemother Pharmacol 30 suppl 1992 S15 S20
8. K. Obata, Y. Ohashi, H. Akaza Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer Cancer Chemother Pharmacol 35 suppl 1994 S88 S92
9. Y. Matsumura, H. Akaza, S. Isaka The 4th study of prophylactic intravesical chemotherapy with adriamycin in the treatment of superficial bladder cancer the experience of the Japanese Urological Cancer Research Group for Adriamycin Cancer Chemother Pharmacol 30 suppl 1992 S10 S14
10. S. Hinotsu, H. Akaza, S. Isaka Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer - the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/ Farmarubicin Gan To Kagaku Ryoho 29 2002 73 80
11. S. Hinotsu, H. Akaza, Y. Ohashi Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection Cancer 86 1999 1818 1826
12. Gan Chiryo Gakkai (Japan Society of Clinical Oncology) Committee Report Nippon Gan Chiryo Gakkai Shi 32 1997 61 65
13. R.J. Gray Some diagnostic methods for Cox regression models through hazard smoothing Biometrics 46 1990 93 102
14. SAS Institute JMP Statistics and Graphic Guide 2000 SAS Institute Cary, North Carolina
15. J.L. Viescas Microsoft Access 97 Official Manual 1997 Microsoft Corporation Tokyo
16. D.L. Lamm, B.A. Blumenstein, E.D. Crawford A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder N Engl J Med 325 1991 1205 1209
17. D.L. Lamm, B.A. Blumenstein, J.D. Crissman Maintenance bacillus Calmette-Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder a randomized Southwest Oncology Group study J Urol 163 2000 1124 1129
18. N. Ikeda, I. Toida, H. Yamada Interaction of bacillus Calmette-Guérin (BCG) with bladder tumor cells Biotherapy 10 1996 879 884
19. C. Durek, E. Richter, A. Basteck The fate of bacillus Calmette-Guérin after intravesical instillation J Urol 165 2001 1765 1768